Key result
Recent coronary thrombi, compared to old thrombi, did not significantly affect the 30-day rate of major cardiovascular events (9.5% vs 6.0%, p=0.53) in patients with STEMI undergoing primary PCI.
Why the study?
Does the histopathological age of aspirated coronary thrombi (recent vs. old) influence 30-day cardiovascular outcomes in patients with STEMI undergoing primary PCI?
Cohort (n=199)
No
Does the histopathological age of aspirated coronary thrombi (recent vs. old) influence 30-day cardiovascular outcomes in patients with STEMI undergoing primary PCI?
The histopathological classification of aspirated coronary thrombi as recent or old does not significantly impact 30-day cardiovascular outcomes in patients with STEMI undergoing primary PCI.
BACKGROUND: Percutaneous Coronary Intervention (PCI) is the most common strategy for the treatment of Acute ST segment elevation Myocardia Infarction (STEMI), and thromboaspiration has been increasingly utilized for removal of occlusive thrombi. OBJECTIVES: To analyze the influence of histopathological features of coronary thrombi in clinical outcomes of patients with STEMI, and the association of these variables with clinical, angiographic, and laboratory features and medications used in hospitalization. METHODS: Prospective cohort study. All patients were monitored during hospitalization and thirty days after the event. Aspirated thrombi were preserved in formalin and subsequently stained with hematoxylin-eosin and embedded in paraffin. Thrombi were classified as recent and old. The primary outcome was the occurrence of major cardiovascular events within thirty days. RESULTS: During the study period, 1,149 patients were evaluated with STEMI, and 331 patients underwent thrombi aspiration, leaving 199 patients available for analysis. It was identified recent thrombi in 116 patients (58%) and old thrombi in 83 patients (42%). Recent thrombi have greater infiltration of red blood cells than old thrombi (p = 0.02), but there were no statistically significant differences between other clinical, angiographic, laboratory, and histopathological features and medications in both group of patients. The rates of clinical outcomes were similar in both groups. CONCLUSIONS: Recent thrombi were identified in 58% of patients with STEMI and it was observed an association with infiltration of red blood cells. There was no association between histopathological features of thrombi and clinical variables and cardiovascular outcomes.
No takes yet. Share an insight, caveat, or question.
Sebben et al. (2013) conducted a cohort in Acute ST segment elevation Myocardial Infarction (STEMI) (n=199). Recent thrombus vs. Old thrombus was evaluated on Major cardiovascular events within 30 days (combination of death, AMI, and myocardial revascularization) (p=0.53). Recent coronary thrombi, compared to old thrombi, did not significantly affect the 30-day rate of major cardiovascular events (9.5% vs 6.0%, p=0.53) in patients with STEMI undergoing primary PCI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: